| Vasculogenic mimicry in small cell lung cancer SC Williamson, RL Metcalf, F Trapani, S Mohan, J Antonello, B Abbott, ... Nature communications 7 (1), 13322, 2016 | 238 | 2016 |
| Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study CJ Morrow, F Trapani, RL Metcalf, G Bertolini, CL Hodgkinson, ... Annals of Oncology 27 (6), 1155-1160, 2016 | 112 | 2016 |
| A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells M Moad, D Pal, AC Hepburn, SC Williamson, L Wilson, M Lako, ... European urology 64 (5), 753-761, 2013 | 98 | 2013 |
| In situ lineage tracking of human prostatic epithelial stem cell fate reveals a common clonal origin for basal and luminal cells JK Blackwood, SC Williamson, LC Greaves, L Wilson, AC Rigas, ... The Journal of pathology 225 (2), 181-188, 2011 | 80 | 2011 |
| Multipotent basal stem cells, maintained in localized proximal niches, support directed long-ranging epithelial flows in human prostates M Moad, E Hannezo, SJ Buczacki, L Wilson, A El-Sherif, D Sims, ... Cell reports 20 (7), 1609-1622, 2017 | 75 | 2017 |
| The MEK5–ERK5 kinase axis controls lipid metabolism in small-cell lung cancer S Cristea, GL Coles, D Hornburg, M Gershkovitz, J Arand, S Cao, T Sen, ... Cancer research 80 (6), 1293-1303, 2020 | 61 | 2020 |
| Side population in human non-muscle invasive bladder cancer enriches for cancer stem cells that are maintained by MAPK signalling AC Hepburn, R Veeratterapillay, SC Williamson, A El-Sherif, N Sahay, ... PloS one 7 (11), e50690, 2012 | 52 | 2012 |
| SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells DJ O'Neill, SC Williamson, D Alkharaif, ICM Monteiro, M Goudreault, ... Epigenetics 9 (7), 942-950, 2014 | 36 | 2014 |
| VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status F Bizzaro, I Fuso Nerini, MA Taylor, A Anastasia, M Russo, G Damia, ... Journal of Hematology & Oncology 14, 1-7, 2021 | 32 | 2021 |
| A review of tasquinimod in the treatment of advanced prostate cancer SC Williamson, AE Hartley, R Heer Drug Design, Development and Therapy, 167-174, 2013 | 20 | 2013 |
| Human α2β1HI CD133+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor SC Williamson, AC Hepburn, L Wilson, K Coffey, CA Ryan-Munden, D Pal, ... Plos one 7 (11), e48944, 2012 | 19 | 2012 |
| Characterisations of human prostate stem cells reveal deficiency in class I UGT enzymes as a novel mechanism for castration-resistant prostate cancer SC Williamson, R Mitter, AC Hepburn, L Wilson, A Mantilla, HY Leung, ... British journal of cancer 109 (4), 950-956, 2013 | 17 | 2013 |
| Prostate specific antigen enhances the innate defence of prostatic epithelium against Escherichia coli infection CL Townes, A Ali, N Gross, D Pal, S Williamson, R Heer, CN Robson, ... The Prostate 73 (14), 1529-1537, 2013 | 16 | 2013 |
| Renal differentiation from adult spermatogonial stem cells R Heer, AC Hepburn, SC Williamson, A Kennedy, A El-Sherif, NA Soomro, ... Renal failure 35 (10), 1387-1391, 2013 | 14 | 2013 |
| Functional networks inference from rule-based machine learning models N Lazzarini, P Widera, S Williamson, R Heer, N Krasnogor, J Bacardit BioData mining 9, 1-23, 2016 | 12 | 2016 |
| Trade in live reptiles and its impact on reptile diversity: the European pet market as a case study M Auliya, S Altherr, D Ariano-Sanchez, EH Baard, C Brown, JC Cantu, ... Biological Conservation 204 (A), 103-119, 2016 | 7 | 2016 |
| Vasculogenic mimicry in small cell lung cancer. Nat Commun. 2016; 7: 13322 SC Williamson, RL Metcalf, F Trapani, S Mohan, J Antonello, B Abbott, ... | 6 | |
| The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and … M Lawson, N Cureton, S Ros, A Cheraghchi-Bashi, J Urosevic, S D'Arcy, ... Cancer Research 83 (23), 3989-4004, 2023 | 5 | 2023 |
| Combining the AKT inhibitor capivasertib and SERD fulvestrant is effective in palbociclib-resistant ER+ breast cancer preclinical models L Hopcroft, EM Wigmore, SC Williamson, S Ros, C Eberlein, JI Moss, ... NPJ Breast Cancer 9 (1), 64, 2023 | 4 | 2023 |
| Lineage plasticity in SCLC generates non-neuroendocrine cells primed for vasculogenic mimicry SM Pearsall, SC Williamson, S Humphrey, E Hughes, D Morgan, ... Journal of Thoracic Oncology 18 (10), 1362-1385, 2023 | 2 | 2023 |
